Abstract
Pancreatic neuroendocrine tumors (PNETs) are considered rare pancreatic neoplasms, and it is a challenging disease entity due to its indolent behavior and is difficult to manage. Diagnostic challenge is usually found in the imaging-based approach, such as transabdominal ultrasound, abdominal CT scan, and abdominal MRI. Surgery is still the main key player in controlling the disease. The main problems in clinical practice are the early detection of small PNETs lesion and non-functional PNET (NF-PNET) cases. Most cases usually come with large tumor size or metastatic disease. Endoscopic ultrasound (EUS) has been well-known as the most sensitive tool for early detection of pancreatic malignancy. It has now also been developed for managing pancreatic cancer, such as tumor ablation therapy. We presented four variety of PNETs cases (one patient with non-functioning PNETs and three patients with functioning PNETs) who have been successfully treated with EUS-guided radiofrequency ablation (RFA) with good control of tumor growth during follow-up. One patient with a large-size insulinoma could have the tumor controlled gradually after several EUS-RFA sessions. No adverse events or major complications were observed during and after the EUS-RFA procedure. EUS has been shown as a promising tool not only for more accurate diagnosis but also for tumor growth control. However, it would need further comparison studies between EUS and surgical approaches to make a better treatment strategy.
Similar content being viewed by others
Availability of data and materials
The datasets for this study can be obtained by contacting the corresponding author.
Abbreviations
- EUS:
-
Endoscopic ultrasound
- NET:
-
Neuroendocrine tumor
- PNET:
-
Pancreatic neuroendocrine tumor
- RFA:
-
Radiofrequency ablation
References
Kanthan R, Senger J-L, Ahmed S, et al. Pancreatic neuroendocrine tumors in the 21st Century-an update. J Cancer Ther. 2017;8:1194–233.
Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19:1727–33.
Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. analysis of autopsy cases. Dig Dis Sci. 1991;36:933–42.
Khanna L, Prasad SR, Sunnapwar A, et al. Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification. Radiographics. 2020;40:1240–62.
McKenna LR, Edil BH. Update on pancreatic neuroendocrine tumors. Gland Surg. 2014;3:258–75.
Chong CCN, Tang RSY, Wong JCT, et al. Endoscopic ultrasound of pancreatic lesions. J Vis Surg. 2016;2:119.
Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50:392–401.
Date RS, Biggins J, Paterson I, et al. Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas. 2005;30:266–71.
Fraenkel M, Kim MK, Faggiano A, et al. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26:691–703.
Guilmette JM, Nose V. Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances. Adv Anat Pathol. 2019;26:13–30.
Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829–37.
Lakhtakia S, Ramchandani M, Galasso D, et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc. 2016;83:234–9.
Pai M, Habib N, Senturk H, et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7:52–9.
de Nucci G, Imperatore N, Mandelli ED, et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series. Endosc Int Open. 2020;8:E1754–8.
Ueda K, Taira T, Hakoda H, et al. Giant insulinoma: report of a case and review of published reports. Surg Case Rep. 2016;2:136.
DiMagno EP, DiMagno MJ. Endoscopic ultrasonography: from the origins to routine EUS. Dig Dis Sci. 2016;61:342–53.
Lesmana CRA. Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy. World J Gastrointest Surg. 2023;15:163–8.
Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann of Surg. 1999;230:1–8.
Garg R, Mohammed A, Singh A, et al. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Endosc Ultrasound. 2022;11:170–85.
Takahashi D, Kojima M, Suzuki T, et al. Profiling the tumour immune microenvironment in pancreatic neuroendocrine neoplasms with multispectral imaging indicates distinct subpopulation characteristics concordant with WHO 2017 classification. Sci Rep. 2018;8:13166.
Oh D, Seo DW, Song TJ, et al. Clinical outcomes of EUS-guided radiofrequency ablation for unresectable pancreatic cancer: a prospective observational study. Endosc Ultrasound. 2022;11:68–74.
Acknowledgements
The author would like to thank Dr. Monica Mangkuwerdojo, a radiologist at Medistra Hospital, Dr. Rio Hermawan, a senior consultant interventional radiologist at MRCCC Siloam Semanggi Hospital, and Nurse Yulia Estu Pratiwi P.N., my teamwork in both hospitals, who helped to collect patients' data and images.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
CRA Lesmana: Conceptualization, investigation, writing-original draft, writing-review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that they have no conflicts of interest.
Ethical approval
This case series study is part of an ongoing study that has been approved by The Health Research Ethics Committee of the Medistra Hospital with the reference number: 003/EA/KEPKM/2023.
Consent to participate
Not applicable.
Consent to publication
Informed consent to publish images was obtained from relevant participants.
Informed consent
The patients have been informed regarding their's possible images used for publication in the manuscript. Patient's consent have been taken related to the images used.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lesmana, C.R.A. Endoscopic loco-regional treatment in controlling pancreatic neuroendocrine tumors (PNETs) behavior: a case series and literature review. Clin J Gastroenterol (2024). https://doi.org/10.1007/s12328-024-01959-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12328-024-01959-2